IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING
coated tab lets 41%
am poules 16%
tab lets 12%
cap sules 10%
in fu sions 8%
SANDOZ
Full Name: Sandoz Pharmaceuticals AG
Postal Ad dress: Postfach 5051, CH-6330 Cham
2
Street Ad dress: Hinterbergstrasse 24, CH-6330
Cham
Tel: +41 61 324 11 11
Fax: +41 61 324 80 01
Sub sid iary of: Novartis, Swit zer land (100%)
Phar ma ceu ti cal Sales: US$ 150-160 mil lion
Prod ucts (% of Sales by Lead ing 5): 35-40%
Ther a peu tic Classes (% of Sales by Lead ing
5): 55-60%
Dose Forms (% of Sales by Lead ing 5):
90-95%
Prin ci pal Prod ucts:
OMEPRAZOL SDZ ECO (antiulcerant)
SIMCORA (cho les terol/triglyceride reg u lat ing
prep a ra tion)
CITALOPRAM ECOSOL (an ti de pres sant)
ECOFENAC (antirheumatic non-steroidal;
antirheumatic top i cal)
TORASIS (di uretic)
Ther a peu tic Range:
psychoanaleptics 13%
ant ac ids/antiflatulents/antiulcerants 13%
lipid-reg u lat ing/antiatheroma prep a ra tions
12%
antibacterials sys temic 10%
beta-block ing agents 8%
Lead ing Dose Forms:
coated tab lets 43%
tab lets 32%
cap sules 15%
gels/sols 2%
pow ders/gran ules 2%
SYRIA
NOVARTIS
Full Name: Novartis Pharma Ser vices AG
Postal Ad dress: PO Box 3551, Da mas cus
Street Ad dress: Abou Roumaneh, Ab dul Al
Malek Ibn Marwan str., Sabbagh & Tarabishi
Bldg., 1st floor, Da mas cus
Tel: +963 11 334 0115
Fax: +963 11 334 0046
TAIWAN
CIBA VI SION
Full Name: CIBA Vi sion Tai wan Co., Ltd.
Street Ad dress: 10F, No.131, ASec.3,
Min-Sheng Est. Road, Tai pei 105
Tel: +886 2 3518-5678
Fax: +886 2 2715-2358
Home Page: www.cibavision.com.tw
NOVARTIS
Full Name: Novartis (Tai wan) Co., Ltd.
Street Ad dress: 11Fl. No.99, Sec.2, Jen-Ai
Road, Tai pei 100
Tel: +886 e 2341-6580
Fax: +886 2 2343-2096
Home Page: www.tw.novartis.com
De scrip tion: Re searcher, im porter, pro moter,
sales/detailer. Prod uct ranges in clude: phar ma -
ceu ti cal prod ucts (branded, pre scrip tion,
non-pre scrip tion), hos pi tal pharmaceuticals, di -
etetic/nu tri tional prod ucts, med i cal equip ment,
oph thal mic prod ucts. Es tab lished 1997. 430 phar -
ma ceu ti cal em ploy ees in 2007. Di vi sions in clude:
Phar ma ceu ti cal division; Consumer Health
division.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 101-500 (2007)
Con tacts (Pharm): Chair man: Alex Chang;
Com mer cial Op er a tions: Satina Lin, Sid Lin; Mar -
ket Re search: Nick Wang; Re search & De vel op -
ment: J.C. Wu; Gen eral Con tact: Linda Liu
Sub sid iary of: Novartis, Swit zer land (100%)
Phar ma ceu ti cal Sales: US$ 180-190 mil lion
Prod ucts (% of Sales by Lead ing 5): 60-65%
Ther a peu tic Classes (% of Sales by Lead ing
5): 65-70%
Dose Forms (% of Sales by Lead ing 5):
90-95%
Prin ci pal Prod ucts:
DIOVAN (an gio ten sin-II an tag o nist plain)
GLIVEC (antineoplastic other)
CO-DIOVAN (an gio ten sin-II an tag o nist com bi na -
tion)
LESCOL XL (cho les terol/triglyceride reg u lat ing
prep a ra tion)
SANDIMMUN NEORAL (immunosuppressive
agent)
Ther a peu tic Range:
renin-an gio ten sin sys tem agents 33%
© 2009 IMS Health In cor po rated or its af fil i ates Page 214